Gamma-hydroxybutyrate (GHB or sodium oxybate) is both an exogenous and endogenous molecule with neuromodulator properties. In the United States, GHB is an approved drug for the treatment of narcolepsy and narcolepsy with cataplexy in adults. In some European Union countries, sodium oxybate is applied for the treatment of opioid and alcohol withdrawal.
|Numero di pagine||9|
|Rivista||Current Drug Metabolism|
|Stato di pubblicazione||Published - 2017|
All Science Journal Classification (ASJC) codes
- Clinical Biochemistry
Ventura Spagnolo, E., Calapai, F., Navarra, M., Mannucci, C., Calapai, G., Gangemi, S., & Pichini, S. (2017). Sodium oxybate therapy for the treatment of alcohol withdrawal syndrome and the maintenance of alcohol abstinence. Current Drug Metabolism, 19.